Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-29
1996-12-17
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 514212, 5142282, 514253, 514254, 514256, 5142345, 514322, 514359, 514381, 514383, 514338, 544 62, 544139, 544238, 544242, 544336, 544370, 546199, 5462737, 548250, 548255, 5482622, A16K 31415, C07D23526, C07D23522, C07D40302
Patent
active
055853943
ABSTRACT:
The present invention relates to 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives of the formula: ##STR1## to their preparation and to the pharmaceutical compositions in which they are present. These derivatives have an affinity for the vasopressin and oxytocin receptors.
REFERENCES:
patent: 3405136 (1968-10-01), Wright
patent: 3849431 (1974-11-01), Gallay et al.
patent: 4205077 (1980-05-01), Aufderhaar et al.
patent: 4916149 (1990-04-01), Palosi et al.
patent: 5338755 (1994-08-01), Wagnon et al.
Achour, Reddouane; Zniber, Rachid Bull. Soc. Chim. Belg. (1987), 96(10), 787-92.
Di Malta Alain
Garcia Georges
Mettefeu Daniel
Nisato Dino
Roux Richard
McKane Joseph
Sanofi
Stockton Laura L.
LandOfFree
1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991597